IGM Biosciences Inc expected to post a loss of 80 cents a share - Earnings Preview

IGM Biosciences

08/11/2024 15:49

* IGM Biosciences Inc  IGMS.OQ   IGMS.O  is expected to show
a
fall in quarterly revenue when it reports  results on November
11 (estimated) for the period ending September 30 2024
    * The Mountain View California-based  company is expected to
report a 47.5% decrease in revenue to $267.22 thousand from $509
thousand a year ago, according to the mean estimate from 9
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for IGM Biosciences Inc is
for a
loss of 80 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for IGM
Biosciences
Inc is $17.50​, above​ its last closing price of $14.37. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.02       -0.04      -0.79     Missed  -1,991
                                                        .1
 Jan. 1 2024   -0.83       -0.83      -0.83     Met     0.2
 Dec. 31 2023  -0.96       -1.03      -1.01     Beat    2.2​
 Sep. 30 2023  -1.18       -1.21      -1.04     Beat    14.3
 ​​Jun.        -1.44       -1.43      -1.43     Met     0.3
 30 2023                                                
 Mar. 31 2023  -1.34       -1.36      -1.33     Beat    2.5​
 Dec. 31 2022              -1.25      -1.19     Beat    4.5
 Sep. 30 2022  -1.44       -1.43      -1.32     Beat    7.5
 This summary was machine generated November 8 at 15:49 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)